Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
1.530
-0.060 (-3.77%)
At close: May 17, 2024, 4:00 PM
1.500
-0.030 (-1.96%)
After-hours: May 17, 2024, 4:03 PM EDT
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SNSE stock have an average target of 4.50, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 194.12% from the current stock price of 1.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SNSE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $5 | Buy | Initiates | $5 | +226.80% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +161.44% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +292.16% | Dec 13, 2022 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +226.80% | Oct 3, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +553.59% | Mar 10, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.03
from -1.22
EPS Next Year
-1.07
from -1.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.68 | -0.91 | -0.49 |
| Avg | -1.03 | -1.07 | -0.89 |
| Low | -1.26 | -1.18 | -1.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.